Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer

BACKGROUND: Stereotactic ablative radiotherapy (SABR) is recommended as first-choice treatment to inoperable early-stage non-small cell lung cancer (NSCLC). However, it is not widely adopted in developing countries, and its cost-effectiveness is unclear. We aimed to perform a systematic review of fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Maia, Fernando Henrique de Albuquerque, Rozman, Luciana Martins, Carvalho, Heloisa de Andrade, de Soárez, Patrícia Coelho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841623/
https://www.ncbi.nlm.nih.gov/pubmed/36647118
http://dx.doi.org/10.1186/s12962-023-00415-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841623/
https://www.ncbi.nlm.nih.gov/pubmed/36647118
http://dx.doi.org/10.1186/s12962-023-00415-1

Ejemplares similares